Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
2014 · Molecular Therapy — Nucleic Acids · 68 citations
https://doi.org/10.1038/mtna.2014.30
E
Evan Geller
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
6.0K
Citations
10
h-index
10
i10-index
Evan Geller is an academic researcher from New York Genome Center. The author has contributed to research in topics: Genomics and Chromatin Dynamics & RNA Research and Splicing & CRISPR and Genetic Engineering. The author has an h-index of 10, co-authored 18 publications.
ORCID: 0000-0002-8035-8736Papers by this author
worksMassively parallel disruption of enhancers active in human neural stem cells
2024 · Cell Reports · 17 citations
https://doi.org/10.1016/j.celrep.2024.113693
Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers
2025 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-025-56568-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat